SCHEMBL6623864

SCHEMBL6623864

NS(=O)(=O)c1ccc(-c2ccccc2)cc1-c1nccs1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDPK1 O15530 1/20 0.49
SLC6A9 P48067 1/20 0.47
PTGDR2 Q9Y5Y4 1/20 0.45
CA2 P00918 3/20 0.43
CA9 Q16790 3/20 0.43
ENPP3 O14638 1/20 0.43
KDR P35968 1/20 0.42
ACLY P53396 1/20 0.41
SCN9A Q15858 2/20 0.41
KAT6A Q92794 1/20 0.40
CA12 O43570 2/20 0.40
CA1 P00915 2/20 0.40
HDAC2 Q92769 1/20 0.39
CHEK2 O96017 1/20 0.38
LRRK2 Q5S007 1/20 0.38
P2RX4 Q99571 1/20 0.38
LOXL2 Q9Y4K0 1/20 0.38
CYP2A6 P11509 1/20 0.38
ADORA2A P29274 1/20 0.38
ADORA1 P30542 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6681646 0.89 GABRA1 (0.41) SLC6A9PTGDR2CA2CA9ENPP3
SCHEMBL28816427 0.89 LOXL2 (0.45) PDPK1PTGDR2CA2CA9ENPP3
SCHEMBL6624144 0.85 PTPRC (0.43) CA2CA9ENPP3CA12CA1
SCHEMBL20899928 0.84 SLC6A11 (0.42) PDPK1PTGDR2CA2CA9ENPP3
SCHEMBL20899966 0.83 CA2 (0.43) CA2CA9ENPP3CA12CA1
SCHEMBL29608350 0.81 ADORA2A (0.47) PDPK1CA2CA9ENPP3CA12
SCHEMBL1093747 0.81 ADORA2A (0.47) PDPK1CA2CA9ENPP3CA12
SCHEMBL5692973 0.81 SCN9A (0.46) PDPK1CA2CA9SCN9ACA1
SCHEMBL3838065 0.80 ALDH1A1 (0.39) PDPK1CA2CA9ENPP3CA12
SCHEMBL30130504 0.80 ALDH1A1 (0.39) PDPK1CA2CA9ENPP3CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004112783-A1 NEW USE IV BIOVITRUM AB (SE) 2004-12-29 WO claimed
EP-1461325-A1 INHIBITORS OF 11-BETA-HYDROXY STEROID DEHYDROGENASE TYPE 1 BIOVITRUM AB (SE) 2004-09-29 EP claimed
WO-2003043999-A1 INHIBITORS OF 11-BETA-HYDROXY STEROID DEHYDROGENASE TYPE 1 BIOVITRUM AB (SE) 2003-05-30 WO claimed
WO-2019075394-A1 COMPOUNDS FOR TREATMENT OF EMOTIONAL/PSYCHOLOGICAL SYMPTOMS IN FRAGILE X SYNDROME VANDERKLISH PETER (US) 2019-04-18 WO disclosed